CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 77 filers reported holding CYTOMX THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 2.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $28,551 | +16.2% | 15,350 | 0.0% | 0.00% | – |
| Q1 2023 | $24,560 | -1.8% | 15,350 | -0.1% | 0.00% | – |
| Q4 2022 | $25,000 | +13.6% | 15,364 | 0.0% | 0.00% | – |
| Q3 2022 | $22,000 | -21.4% | 15,364 | 0.0% | 0.00% | – |
| Q2 2022 | $28,000 | +2700.0% | 15,364 | +4627.4% | 0.00% | – |
| Q1 2022 | $1,000 | – | 325 | +2221.4% | 0.00% | – |
| Q4 2021 | $0 | – | 14 | -6.7% | 0.00% | – |
| Q3 2021 | $0 | – | 15 | -67.4% | 0.00% | – |
| Q2 2021 | $0 | – | 46 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 5,576,471 | $36,526,000 | 1.44% |
| Altium Capital Management LP | 273,703 | $1,793,000 | 0.67% |
| Jackson Creek Investment Advisors LLC | 80,367 | $526,000 | 0.21% |
| HARBOURVEST PARTNERS LLC | 79,193 | $519,000 | 0.20% |
| XTX MARKETS LLC | 14,169 | $93,000 | 0.19% |
| Perceptive Advisors | 2,577,043 | $16,880,000 | 0.18% |
| RTW INVESTMENTS, LP | 1,527,352 | $10,004,000 | 0.17% |
| Exane Asset Management | 30,568 | $200,220,000 | 0.14% |
| Virtus ETF Advisers LLC | 37,343 | $245,000 | 0.10% |
| Congress Park Capital LLC | 25,807 | $169,000 | 0.10% |